The androgen receptor: a potential target for therapy of prostate cancer
Authors:
- H. HuangHHH. Huang
- D.J. TindallDTD.J. Tindall
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Improvements in benign prostatic hyperplasia‐specific quality of life with dutasteride, the novel dual 5α‐reductase inhibitorBJU International, 2003
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Role of PI3K Signaling in Survival and Progression of LNCaP Prostate Cancer Cells to the Androgen Refractory StateEndocrinology, 2001
- Treatment Options in Hormone-Refractory Prostate CancerDrugs, 2001
- Two Opposing Effects of Non-steroidal Anti-inflammatory Drugs on the Expression of the Inducible CyclooxygenaseJournal of Biological Chemistry, 2000
- PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCERJournal of Urology, 2000
- Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissueThe Journal of Steroid Biochemistry and Molecular Biology, 1999
- Activation of the Human Androgen Receptor through a Protein Kinase A Signaling PathwayJournal of Biological Chemistry, 1996
- The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate tumor cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Diet and serum sex hormones in healthy menJournal of Steroid Biochemistry, 1984